Abstract:Background: Clinically, some patients whose HBsAg becomes negative owing to antiviral therapy or spontaneously still show a low level of HBV DNA persistence in serum. T-lymphocyte subsets, cytokine levels and HBV S gene sequences were analyzed in this study. Methods: A total of 52 HBsAg-negative and HBV DNA-positive patients(HBsAg-/HBV DNA+ patients), 52 persistently HBsAg-positive patients(HBsAg+/HBV DNA+ patients) and 16 healthy people were evaluated. T-lymphocyte subsets of these patients were detected by flow cytometry, serum cytokines and chemokines were detected by the Luminex technique, and the HBV S region was evaluated by Sanger sequencing. T%, T-lymphocyte, CD8+ and CD4+T lymphocyte were lower in the HBsAg-negative group than in the HC group. Compared with the HBsAg-positive group, the HBsAg-negative group had lower levels in T lymphocyte %, CD8+T lymphocyte %, CD8+T lymphocyte and CD4/CD8. These difference were statistically significant ( P <0.05). Serum IFN-γ, IFN-α and FLT-3L levels were significantly higher in the HBsAg-negative group than in the HBsAg-positive group ( P <0.05). However, levels of many cytokines related to inflammation (i.e., IL-6, IL-8, IL10, IL-12, IL-17A) were lower in the HBsAg-negative group. Fifty-two HBsAg-negative samples were sequenced, revealing high-frequency amino acid substitution sites in the HBV S protein, including immune escape mutations (i.e., Y100C, S114T, C124Y, P127L, G130R, T131N, M133T, C137S, G145A) and TMD region substitutions (i.e., E2K/R/D, G7D/R, G10D, A17R, F20L/S, L21V, L22V). Conclusions: According to the results of T-lymphocyte subsets and serum cytokines, it can be deduced that the cellular immune function of HBsAg-negative patients is superior to that of HBsAg-positive patients, with attenuation of liver inflammation. HBsAg-negative patients may show a variety of mutations and amino acid replacement sites at high frequency in the HBV S region, and these mutations may lead to undetectable HBsAg, HBsAg antigenic changes or secretion inhibition.

Class Ⅱ transactivator promoter Ⅳ involved in immune-tolerant phase of HBV persistent infection

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Immune Checkpoint Molecules Expressed on CD4+ T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers with Hepatitis B E Antigen-Negative

Analysis on Clinical Features and Immunity in Chronic Hepatitis B Virus Infected Patients with Low-Level Hbsag

Association of CD40 -1C/T Polymorphism in the 5′-Untranslated Region with Chronic HBV Infection

Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B

Molecular Profile of the T Cell Receptor Beta Variable in Peripheral Blood Lymphocytes from Chronic Asymptomatic HBV Carriers

The Study on the Relationship Between Expression of B7-H1 on HBV Transgenic Mice and Immune Toler-Ance to HBV

The Frequency and Skewed T-Cell Receptor Beta-Chain Variable Patterns of Peripheral Cd4(+)Cd25(+) Regulatory T-Cells Are Associated with Hepatitis B E Antigen Seroconversion of Chronic Hepatitis B Patients During Antiviral Treatment

A meta-analysis of the relation of polymorphism at the sites-1082,-592 and -819 of IL-10 gene promoter with the susceptibility to hepatitis B virus infection

Association Of T-Cell Immunoglobulin And Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms With Susceptibility And Disease Progression Of Hbv Infection

Genetic variations of type Ⅰ interferon receptor 1 promoter and their association with chronic hepatitis B virus infection

TNF-alpha Promoter Region Polymorphisms Affect HBV Virus Clearance in Southern Chinese.

Expression Profiles and Function of Toll-Like Receptors 2 and 4 in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Patients

Association of Candidate Susceptible Loci with Chronic Infection with Hepatitis B Virus in A Chinese Population

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients

A meta-analysis on the relationship between tumor necrosis factor-αpromoter polymorphisms and chronic hepatitis B virus infection

Relationship Between TNF- Gene Promoter Polymorphisms and Outcomes of Hepatitis B Virus Infections: A Meta-Analysis

Association Between CISH Polymorphisms and Spontaneous Clearance of Hepatitis B Virus in Hepatitis B Extracellular Antigen–positive Patients During Immune Active Phase

Epigenetic regulation of HBV-specific tumor infiltrating T cells in HBV-related HCC

Hypomethylation of Tumor necrosis factor-like cytokine 1A(TL1A) and its decoy receptor 3 expressive level increase has diagnostic value in HBV-associated cirrhosis